What is Radical Numerics?
Radical Numerics is at the vanguard of artificial intelligence research, dedicated to creating general biological intelligence. Their multimodal AI systems are engineered to decipher intricate biological relationships, thereby accelerating breakthroughs in critical areas such as drug discovery, disease diagnostics, biotechnology research, and biosecurity applications. By processing and understanding complex biological data, Radical Numerics aims to unlock new possibilities in healthcare and life sciences.
How much funding has Radical Numerics raised?
Radical Numerics has raised a total of $50M across 1 funding round:
Seed
$50M
Seed (2026): $50M with participation from Triatomic Capital, First Spark Ventures, 315 Columbia, and The Obvious
Key Investors in Radical Numerics
Triatomic Capital
Triatomic Capital is an investment firm focused on deep tech, health tech, and new economy sectors, particularly in AI and automation. They aim to support entrepreneurs in developing 'century-defining' technologies and businesses across various themes such as next-gen computing, engineered biology, and new energy solutions.
First Spark Ventures
First Spark Ventures is a Deep Tech venture capital fund that invests in breakthrough technologies aimed at enhancing health, safety, and productivity. The firm focuses on startups in Advanced Compute, Digital Biology & Biotech, and CyberPhysical Systems, primarily targeting companies in Pre-seed, Seed, and Series A funding rounds.
315 Columbia
Factory LLC is a consumer packaged goods (CPG) operator specializing in the Food, Beverage, and Personal Care sectors. The company provides capital, product innovation, brand building, and operational expertise to help clients scale their businesses.
What's next for Radical Numerics?
With this substantial enterprise-level funding, Radical Numerics is poised for significant expansion and accelerated development. The strategic investment will likely fuel further research into their advanced biological AI models, enhance their computational infrastructure, and broaden their market reach. This capital will enable the company to scale its operations, attract top-tier talent, and solidify its position as a leader in applying AI to solve complex biological challenges, ultimately driving innovation across the healthcare and life sciences industries.
See full Radical Numerics company page
